公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | CrCl36H2O and boric acid as a new catalytic system: Enhanced 5-hydroxymethylfurfural production from cellulose under milder conditions | Nguyen C.V.; Chang Y.-C.; Yoshikawa T.; Masuda T.; Wu K.C.-W. | Nanoscience and Nanotechnology Letters | 5 | 4 | |
2019 | Efficient liquid-phase hydrogenolysis of a lignin model compound (benzyl phenyl ether) using a Ni/carbon catalyst | Matsagar B.M.; Kang T.-C.; Wang Z.-Y.; Yoshikawa T.; Nakasaka Y.; Masuda T.; Chuang L.-C.; Wu K.C.-W. | Reaction Chemistry and Engineering | 32 | 29 | |
2022 | Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Kang Y.-K.; Morita S.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Sameshima H.; Chen L.-T.; Boku N. | Gastric Cancer | 7 | 7 | |
2020 | Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer | Satoh T.; Kang Y.-K.; Chao Y.; Ryu M.-H.; Kato K.; Cheol Chung H.; Chen J.-S.; Muro K.; Ki Kang W.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Tanimoto M.; Chen L.-T.; Boku N. | Gastric Cancer | 43 | 39 | |
2016 | Genome-wide Association Study of Autism Spectrum Disorder in the East Asian Populations | Liu X.; Shimada T.; Otowa T.; Wu Y.-Y.; Kawamura Y.; Tochigi M.; Iwata Y.; Umekage T.; Toyota T.; Maekawa M.; Iwayama Y.; Suzuki K.; Kakiuchi C.; Kuwabara H.; Kano Y.; Nishida H.; Sugiyama T.; Kato N.; Chen C.-H.; Mori N.; Yamada K.; Yoshikawa T.; Kasai K.; Tokunaga K.; Sasaki T.; SUSAN SHUR-FEN GAU | Autism Research | 73 | 65 | |
2018 | Hydrogen Peroxide Assisted Selective Oxidation of 5-Hydroxymethylfurfural in Water under Mild Conditions | Chen C.-T.; Van Nguyen C.; Wang Z.-Y.; Bando Y.; Yamauchi Y.; Bazziz M.T.S.; Fatehmulla A.; Farooq W.A.; Yoshikawa T.; Masuda T.; Wu K.C.-W. | ChemCatChem | 60 | 56 | |
2016 | A metal-free, high nitrogen-doped nanoporous graphitic carbon catalyst for an effective aerobic HMF-to-FDCA conversion | Nguyen C.V.; Liao Y.-T.; Kang T.-C.; Chen J.E.; Yoshikawa T.; Nakasaka Y.; Masuda T.; Wu K.C.-W. | Green Chemistry | 131 | 118 | |
2017 | Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial | Kang Y.-K.; Boku N.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Chen L.-T. | The Lancet | 1656 | 1458 | |
2021 | Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab | Boku N.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Nishiyama T.; Chen L.-T.; Kang Y.-K. | Gastric Cancer | 50 | 43 | |
2020 | A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Chen L.-T.; Satoh T.; Ryu M.-H.; Chao Y.; Kato K.; Chung H.C.; Chen J.-S.; Muro K.; Kang W.K.; KUN-HUEI YEH ; Yoshikawa T.; Oh S.C.; Bai L.-Y.; Tamura T.; Lee K.-W.; Hamamoto Y.; Kim J.G.; Chin K.; Oh D.-Y.; Minashi K.; Cho J.Y.; Tsuda M.; Sameshima H.; Kang Y.-K.; Boku N. | Gastric Cancer | 138 | 130 |